In 1979 it took FDA 35 mos to review a new drug. By 1992 reviews were promised within 12 mos. The more FDA relied on industry to pay for reviews, the greater likelihood of approval. “You don’t survive as a senior official at the FDA unless you’re pro-industry” Dr. Marciniak.